Global Ganja Report

Israel is an emerging player in the international cannabis market, and the industry is embraced by pillars of the country’s political establishment. But every aspect of Israeli society as been impacted by the horrific events of last October 7, and the ensuing war. The cannabis sector has been no exception.

The long-promised crackdown on unlicensed cannabis sales is finally arriving in New York City. The permanent cannabis carnival in Washington Square has been cleared by the police, and unlicensed stores are being raided. Yet, in a bitter irony, obstacles to the licensed retail sector, including legal challenges, continue to mount.

Dasheeda Dawson is “excited to be back home.”

After a long sojourn as a cannabis patient, advocate and entrepreneur in other states, the Brooklyn native is in her home town as New York City’s first cannabis czar—officially, director of Cannabis NYC, a new office created by Mayor Eric Adams.

In a paradox, New York authorities are finally unleashing the long-anticipated crackdown on the state’s legion and proliferating unlicensed cannabis retailers—while the licensing program continues to be slowed by obstacles, including legal challenges.

Rights for medicinal cannabis users in the workplace have not kept pace with the law in states that have embraced medical and even “recreational” use. Now a case in Vermont may push state and federal authorities alike to close the loopholes that allow workers to be dismissed—and denied unemployment insurance—for using state-legal medicine.

Raphael Mechoulam, the ground-breaking cannabis researcher who first isolated and identified THC in 1964, died in Israel at the age of 92. His passing was announced March 10 by Jerusalem's Hebrew University, where Mechoulam co-founded the Multidisciplinary Center for Cannabinoid Research in 2017.

Small producers have long been wary of the cannabis industry coming under domination by multi-state operators with the worst practices of corporate America. But the revelations of Russian oligarch money in the coffers of leading MSO Curaleaf appear to vindicate even the most cynical observers. These follow a slew of controversies concerning product safety and labor rights at the company.

The arrival of a major US multi-state operator in Bangkok is a sign of the global cannabis industry's big ambitions for Thailand, the first Asian country to decriminalize. But with enabling legislation still pending, the regulatory environment remains uncertain.